Defensive Equity Portfolio, Series 50
Ticker Symbol: FBMSOX
|30 Holdings (As of Day of Deposit)
|Consumer Staples (46.66%)
||Altria Group, Inc.
||The Coca-Cola Company
||Constellation Brands, Inc.
||Costco Wholesale Corporation
||The Estee Lauder Companies Inc.
||Mondelez International, Inc.
||Monster Beverage Corporation
||The Procter & Gamble Company
||Tyson Foods, Inc.
|Health Care (53.34%)
||Edwards Lifesciences Corporation
||Eli Lilly and Company
||HCA Healthcare, Inc.
||Johnson & Johnson
||Merck & Co., Inc.
||Novo Nordisk A/S
||Thermo Fisher Scientific Inc.
||UnitedHealth Group Incorporated
||Vertex Pharmaceuticals Incorporated
* As of the close of business on 8/22/19.
Market values are for reference only and are not indicative of your individual
|Not FDIC Insured Not Bank Guaranteed May Lose Value
|Initial Date of Deposit
|Initial Public Offering Price
||$10.00 per Unit
| Portfolio Ending Date
|Fee Accounts Cash CUSIP
|Fee Accounts Reinvestment CUSIP
|Sales Charges (based on a $10 public offering
|Transactional sales charges:
|Creation and Development Fee:
|Maximum Sales Charge:
The deferred sales charge will be deducted in three monthly installments commencing
When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If
the price exceeds $10.00 per unit, you will pay an initial sales charge.
|Maximum Sales Charge:
The maximum sales charge for investors in fee accounts consists of the creation and development fee.
Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges
apply to units purchased as an ineligible asset.
The creation and development fee is a charge of $.050 per unit collected at
the end of the initial offering period. If the price you pay exceeds $10.00 per
unit, the creation and development fee will be less than 0.50%; if the price
you pay is less than $10.00 per unit, the creation and development fee will exceed
In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.
You should consider the portfolio's investment objective, risks, and
charges and expenses carefully before investing. Contact your financial advisor
or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
An investment in this
unmanaged unit investment trust should be made with an
understanding of the risks involved with owning common stocks,
such as an economic recession and the possible deterioration of
either the financial condition of the issuers of the equity
securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks
in both the consumer products and health care sectors which
involves additional risks, including limited diversification. The
companies engaged in the consumer products industry are
subject to global competition, changing government
regulations and trade policies, currency fluctuations, and the
financial and political risks inherent in producing products for
foreign markets. The companies engaged in the health care
sector are subject to fierce competition, high research and
development costs, governmental regulations, loss of patent
protection, and changing consumer spending trends.
An investment in a portfolio containing equity securities of
foreign issuers is subject to additional risks, including currency
fluctuations, political risks, withholding, the lack of adequate
financial information, and exchange control restrictions
impacting foreign issuers.
As the use of Internet technology has become more prevalent
in the course of business, the trust has become more
susceptible to potential operational risks through breaches in
This UIT is a buy and hold strategy and investors should
consider their ability to hold the trust until maturity. There may
be tax consequences unless units are purchased in an IRA or
other qualified plan.
The value of the securities held by the trust may be subject to
steep declines or increased volatility due to changes in
performance or perception of the issuers.